Medivir AB Statistics

Total Valuation

Medivir AB has a market cap or net worth of GBP 17.17 million. The enterprise value is 13.17 million.

Market Cap	17.17M
Enterprise Value	13.17M

Important Dates

The last earnings date was Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+88.71%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	92.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.48
EV / Sales	50.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.07.

Current Ratio	1.37
Quick Ratio	1.37
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.96% and return on invested capital (ROIC) is -45.10%.

Return on Equity (ROE)	-73.96%
Return on Assets (ROA)	-34.83%
Return on Invested Capital (ROIC)	-45.10%
Return on Capital Employed (ROCE)	-103.38%
Revenue Per Employee	25,261
Profits Per Employee	-889,902
Employee Count	10
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.30% in the last 52 weeks. The beta is 0.33, so Medivir AB's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-42.30%
50-Day Moving Average	6.28
200-Day Moving Average	25.92
Relative Strength Index (RSI)	20.00
Average Volume (20 Days)	3,829

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medivir AB had revenue of GBP 252,608 and -8.90 million in losses. Loss per share was -0.08.

Revenue	252,608
Gross Profit	-7.06M
Operating Income	-9.26M
Pretax Income	-8.90M
Net Income	-8.90M
EBITDA	-9.07M
EBIT	-9.26M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 4.51 million in cash and 620,694 in debt, giving a net cash position of 3.89 million.

Cash & Cash Equivalents	4.51M
Total Debt	620,694
Net Cash	3.89M
Net Cash Per Share	n/a
Equity (Book Value)	8.34M
Book Value Per Share	0.07
Working Capital	1.31M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.96M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,665.71%
Pretax Margin	-3,522.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medivir AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-88.71%
Shareholder Yield	-88.71%
Earnings Yield	-51.82%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medivir AB has an Altman Z-Score of -5.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.88
Piotroski F-Score	n/a